Organisation paid for research Program year 2025 Source: CMS Open Payments

Scla Management, LLC

Neither a doctor nor a teaching hospital

Research payments

$296,764

56 payments

Through program year 2025, Scla Management, LLC is reported as receiving $296,764 in research payments, across 56 payments.

By program year

5 rows

Year	Kind	Amount	Payments
2025	Research	$26,416	11
2024	Research	$139,009	10
2023	Research	$44,501	12
2022	Research	$47,746	10
2021	Research	$39,091	13

Breakdown

Who paid Research payments · program years 2021–2025

Nevro Corp. $156,010 11 payments
Abbott Laboratories $122,763 40 payments
Sanofi Pasteur Inc. $17,990 5 payments

Studies the money was for Research payments · program years 2021–2025

PDN-Sensory $136,644 8 payments
Long-Term Real-World Outcomes Study on Patients Implanted With a Neurostimulator (REALITY) $67,256 14 payments
Long-Term Real-World Outcomes Study on Patients Implanted with a Neurostimulator $37,791 5 payments
A Phase I/II, Randomized, Placebo-controlled, Multi-arm, Dose-finding Study to Evaluate the Safety, Efficacy and Immunogenicity of an Acne mRNA Vaccine Candidate in Adults With Moderate to Severe Acne 18 to 45 Years of Age $17,990 5 payments
CA2022-2 US PDN Sensory $10,000 2 payments
Q3-2023 PDN Sensory 145 $9,366 1 payment
NCT03876054--Long-Term Real-World Outcomes Study on Patients Implanted With a Neurostimulator $8,425 6 payments
Spinal Cord Stimulation Trial to Permanent Prediction $4,990 3 payments
Prospective, Randomized, double arm, open-label Study Assessing the Progression of Subjects Receiving a Neuromodulation System and the Impact on Subject Outcomes with Remote Subject Monitoring $2,910 1 payment
Reality $1,300 8 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.